Display options
Cite
Rossi NF, Zenner Z, Rishi AK, et al. AT. Am J Physiol Regul Integr Comp Physiol. 2019;316(2):R172-R185doi: 10.1152/ajpregu.00289.2018.
Rossi, N. F., Zenner, Z., Rishi, A. K., Levi, E., & Maliszewska-Scislo, M. (2019). AT. American journal of physiology. Regulatory, integrative and comparative physiology, 316(2), R172-R185. https://doi.org/10.1152/ajpregu.00289.2018
Rossi, Noreen F, et al. "AT." American journal of physiology. Regulatory, integrative and comparative physiology vol. 316,2 (2019): R172-R185. doi: https://doi.org/10.1152/ajpregu.00289.2018
Rossi NF, Zenner Z, Rishi AK, Levi E, Maliszewska-Scislo M. AT. Am J Physiol Regul Integr Comp Physiol. 2019 Feb 01;316(2):R172-R185. doi: 10.1152/ajpregu.00289.2018. Epub 2019 Jan 09. PMID: 30624974; PMCID: PMC6397354.
Copy Download .nbib Format: NLM
Share it on

Am J Physiol Regul Integr Comp Physiol. 2019 Feb 01;316(2):R172-R185. doi: 10.1152/ajpregu.00289.2018. Epub 2019 Jan 09.

AT.

American journal of physiology. Regulatory, integrative and comparative physiology

Noreen F Rossi, Zachary Zenner, Arun K Rishi, Edi Levi, Maria Maliszewska-Scislo

Affiliations

  1. Departments of Internal Medicine and Physiology, Wayne State University School of Medicine , Detroit, Michigan.
  2. John D. Dingell Veterans Administration Medical Center , Detroit, Michigan.
  3. Department of Oncology, Wayne State University School of Medicine , Detroit, Michigan.
  4. Department of Pathology, Wayne State University School of Medicine , Detroit, Michigan.

PMID: 30624974 PMCID: PMC6397354 DOI: 10.1152/ajpregu.00289.2018

Abstract

The subfornical organ (SFO), a forebrain circumventricular organ that lies outside the blood-brain barrier, has been implicated in arterial pressure and baroreflex responses to angiotensin II (ANG II). We tested whether pharmacological inhibition or selective silencing of SFO ANG II type 1 receptors (AT

Keywords: Goldblatt kidney; angiotensin II; renal sympathetic nerve activity

References

  1. J Physiol Pharmacol. 2008 Dec;59 Suppl 8:47-59 - PubMed
  2. Hypertension. 1983 Mar-Apr;5(2 Pt 2):I155-64 - PubMed
  3. Circ Res. 1974 Nov;35(5):734-41 - PubMed
  4. Am J Physiol Regul Integr Comp Physiol. 2008 Sep;295(3):R741-50 - PubMed
  5. Cell Mol Neurobiol. 2012 Nov;32(8):1353-65 - PubMed
  6. Hypertension. 1980 Jan-Feb;2(1):4-13 - PubMed
  7. Circ Res. 1990 Jun;66(6):1673-80 - PubMed
  8. Physiol Behav. 2013 Sep 10;121:96-102 - PubMed
  9. Exp Brain Res. 1986;62(3):509-14 - PubMed
  10. Hypertension. 2003 Mar;41(3):576-82 - PubMed
  11. Dev Biol. 1995 Jan;167(1):294-306 - PubMed
  12. Physiol Behav. 2007 Jul 24;91(4):413-23 - PubMed
  13. EMBO J. 2014 May 2;33(9):968-80 - PubMed
  14. FASEB J. 1993 May;7(8):678-86 - PubMed
  15. J Renin Angiotensin Aldosterone Syst. 2011 Dec;12(4):440-5 - PubMed
  16. J Lab Clin Med. 2005 Sep;146(3):160-73 - PubMed
  17. Am J Physiol Regul Integr Comp Physiol. 2018 Mar 1;314(3):R447-R458 - PubMed
  18. Proc Natl Acad Sci U S A. 2006 May 16;103(20):7807-12 - PubMed
  19. J Hypertens. 1992 Dec;10(12):1485-91 - PubMed
  20. Am J Physiol Heart Circ Physiol. 2014 Jan 1;306(1):H121-31 - PubMed
  21. Hypertension. 2015 May;65(5):1126-33 - PubMed
  22. J Pharmacol Exp Ther. 1994 Nov;271(2):804-10 - PubMed
  23. Am J Physiol Heart Circ Physiol. 2000 Oct;279(4):H1804-12 - PubMed
  24. Hypertension. 1991 May;17(5):707-19 - PubMed
  25. J Physiol. 2018 Aug;596(15):3217-3232 - PubMed
  26. Am J Physiol Regul Integr Comp Physiol. 2013 May 15;304(10):R818-28 - PubMed
  27. Am J Physiol Heart Circ Physiol. 2005 Jul;289(1):H426-31 - PubMed
  28. Br J Pharmacol. 1970 Nov;40(3):542P-543P - PubMed
  29. J Am Soc Hypertens. 2008 Sep-Oct;2(5):326-31 - PubMed
  30. J Physiol. 2001 Nov 1;536(Pt 3):667-75 - PubMed
  31. News Physiol Sci. 1998 Aug;13:170-176 - PubMed
  32. J Hypertens. 1988 Jan;6(1):79-84 - PubMed
  33. Am J Physiol Regul Integr Comp Physiol. 2015 Dec 1;309(11):R1309-25 - PubMed
  34. Prog Brain Res. 1992;91:219-33 - PubMed
  35. Clin Exp Pharmacol Physiol. 2001 Dec;28(12):972-5 - PubMed
  36. Am J Physiol. 1995 Mar;268(3 Pt 2):R625-33 - PubMed
  37. Neurosci Lett. 1993 Feb 19;150(2):153-8 - PubMed
  38. Am J Physiol Regul Integr Comp Physiol. 2012 Feb 15;302(4):R424-32 - PubMed
  39. Exp Physiol. 2016 Jan;101(1):67-80 - PubMed
  40. Clin Exp Pharmacol Physiol. 1992 Aug;19(8):587-97 - PubMed
  41. Circ Res. 1990 Dec;67(6):1309-22 - PubMed
  42. Am J Physiol Heart Circ Physiol. 2002 Jun;282(6):H2039-45 - PubMed
  43. Neuroscience. 2016 Aug 4;329:112-21 - PubMed
  44. Am J Physiol Regul Integr Comp Physiol. 2013 Dec;305(11):R1390-400 - PubMed
  45. J Clin Hypertens (Greenwich). 2008 Jul;10(7):522-33 - PubMed
  46. Int J Hypertens. 2013;2013:175428 - PubMed
  47. Exp Neurol. 1995 Aug;134(2):192-8 - PubMed
  48. Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H680-5 - PubMed
  49. Am J Physiol. 1976 Sep;231(3):954-60 - PubMed
  50. Am J Physiol. 1980 Nov;239(5):R382-9 - PubMed
  51. Am J Physiol Regul Integr Comp Physiol. 2004 Apr;286(4):R764-70 - PubMed
  52. Clin Exp Pharmacol Physiol. 2005 May-Jun;32(5-6):462-6 - PubMed
  53. Am J Physiol Regul Integr Comp Physiol. 2016 Jan 15;310(2):R197-208 - PubMed
  54. Physiol Rev. 2004 Jan;84(1):169-208 - PubMed
  55. Neuroendocrinology. 1980 Dec;31(6):380-4 - PubMed
  56. Hypertension. 2013 Mar;61(3):716-22 - PubMed
  57. Brain Res Mol Brain Res. 1995 May;30(1):53-60 - PubMed

Substances

MeSH terms

Publication Types

Grant support